However, the recommended screening is not utilized in many cases (utilization rate <25%), and the diagnostic accuracy of ultrasound and AFP is suboptimal [10]; as a consequence, most HCC tumors are diagnosed at late stages, and median survival remains as less than one year [11]. Here, AFP is linked to hepatocellular carcinoma.